Bleakley Financial Group’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,697
| Closed | -$212K | – | 571 |
|
|
2025
Q1 | $212K | Sell |
10,697
-6,042
| -36% | -$120K | 0.01% | 502 |
|
|
2024
Q4 | $287K | Buy |
16,739
+6,498
| +63% | +$111K | 0.01% | 811 |
|
|
2024
Q3 | $205K | Buy |
10,241
+37
| +0.4% | +$740 | 0.01% | 919 |
|
|
2024
Q2 | $114K | Sell |
10,204
-151
| -1% | -$1.69K | ﹤0.01% | 945 |
|
|
2024
Q1 | $68.3K | Hold |
10,355
| – | – | ﹤0.01% | 950 |
|
|
2023
Q4 | $46.8K | Sell |
10,355
-103
| -1% | -$466 | ﹤0.01% | 926 |
|
|
2023
Q3 | $37.4K | Sell |
10,458
-564
| -5% | -$2.02K | ﹤0.01% | 860 |
|
|
2023
Q2 | $40.7K | Sell |
11,022
-340
| -3% | -$1.26K | ﹤0.01% | 904 |
|
|
2023
Q1 | $37.6K | Buy |
+11,362
| New | +$37.6K | ﹤0.01% | 884 |
|